{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:47:59Z","timestamp":1791110879411,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The benefits of hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) for colorectal cancer with peritoneal metastasis (CPM) remain controversial. R0 resection without peritoneal stripping might be as effective as CRS plus HIPEC. The authors aimed to compare the long-term oncological outcomes of patients with CPM and peritoneal cancer index (PCI) scores less than or equal to 6 who underwent R0 resection in Japan with those who underwent CRS plus HIPEC in Korea.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>This international, retrospective cohort study was conducted in Korea and Japan using a prospectively collected clinical database. Patients who underwent surgery from July 2014 to December 2021 for CPM with a PCI score of less than or equal to 6 and completeness of the cytoreduction score-0 were included. The primary outcome was relapse-free survival (RFS), and the secondary outcomes were overall survival, peritoneal RFS (PRFS), and postoperative outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The 3-year RFS was significantly longer in the CRS+HIPEC group than in the R0 resection group: 35.9% versus 6.9% (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001); 31.0% versus 6.7% (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.040) after propensity score matching. The median PRFS was significantly longer in the CRS+HIPEC group than in the R0 resection group: 24.5 months versus 17.2 months (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.017). The 3-year overall survival and postoperative complications did not significantly differ between the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>RFS and PRFS rates were significantly prolonged after CRS plus HIPEC, whereas postoperative complications and length of hospital stay were not increased. Therefore, curative CRS plus HIPEC may be considered a treatment strategy for selected patients with resectable CPM and low PCI scores.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000000809","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:00:14Z","timestamp":1696579214000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: a collaborative observational study from Korea and Japan"],"prefix":"10.1097","volume":"110","author":[{"given":"Daichi","family":"Kitaguchi","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, National Cancer Center Hospital East, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyuk","family":"Baik","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine"},{"name":"Mirae Medical Check-up Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoma","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, National Cancer Center Hospital East, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Tsukada","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, National Cancer Center Hospital East, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, National Cancer Center Hospital East, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","article-title":"Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study","volume":"47","author":"Lurvink","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ejso.2018.07.061","article-title":"Autopsy of an expert consensus: end of hyperthermic intraperitoneal chemotherapy in colorectal carcinomatosis","volume":"44","author":"Evrard","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","article-title":"HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road?","volume":"45","author":"Ceelen","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/codi.13593","article-title":"Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines","volume":"19","author":"Klaver","year":"2017","journal-title":"Colorectal Dis"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"e6632","DOI":"10.1097\/MD.0000000000006632","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: clinical outcomes at 2 tertiary referral centers in Korea","volume":"96","author":"Park","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3393\/ac.2020.00759.0108","article-title":"Prognostic factors affecting disease-free survival and overall survival in T4 colon cancer","volume":"37","author":"Eom","year":"2021","journal-title":"Ann Coloproctol"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3393\/ac.2021.00920.0131","article-title":"Treatment for peritoneal metastasis of patients with colorectal cancer","volume":"37","author":"Kim","year":"2021","journal-title":"Ann Coloproctol"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3393\/ac.2021.00703.0100","article-title":"Extended lymphadenectomy in locally advanced rectal cancers: a systematic review","volume":"38","author":"Mahendran","year":"2022","journal-title":"Ann Coloproctol"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3393\/ac.2021.00976.0139","article-title":"Clinicopathologic characteristics of early-onset colorectal cancer","volume":"38","author":"Park","year":"2022","journal-title":"Ann Coloproctol"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer","volume":"25","author":"Hashiguchi","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10147-021-01881-4","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the clinical practice of hereditary colorectal cancer","volume":"26","author":"Tomita","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00535-015-1122-8","article-title":"Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis","volume":"51","author":"Sato","year":"2016","journal-title":"J Gastroenterol"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1245\/s10434-017-6133-7","article-title":"Long-term outcomes after R0 resection of synchronous peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy","volume":"25","author":"Shida","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10147-019-01562-3","article-title":"Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum","volume":"25","author":"Shida","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"98","author":"Portilla","year":"2008","journal-title":"J Surg Oncol"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.21072","article-title":"Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy","volume":"98","author":"Gonz\u00e1lez-Moreno","year":"2008","journal-title":"J Surg Oncol"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"suppl 1","key":"R20-20250824","first-page":"S2","article-title":"Management of peritoneal metastases\u2014basic concepts","volume":"20","author":"Sugarbaker","year":"2015","journal-title":"J BUON"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1245\/s10434-018-6436-3","article-title":"Prognostic impact of R0 resection and targeted therapy for colorectal cancer with synchronous peritoneal metastasis","volume":"25","author":"Shida","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","article-title":"The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)","volume":"44","author":"Bushati","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Trans"},{"key":"R24-20250824","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"R25-20250824","first-page":"F413","article-title":"A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat","volume":"248","author":"Flessner","year":"1985","journal-title":"Am J Physiol"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamaoncol.2021.0580","article-title":"Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review","volume":"7","author":"van Stein","year":"2021","journal-title":"JAMA Oncol"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","article-title":"The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Prada-Villaverde","year":"2014","journal-title":"J Surg Oncol"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-022-09572-7","article-title":"GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases","volume":"22","author":"Pereira","year":"2022","journal-title":"BMC Cancer"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamasurg.2021.1642","article-title":"Perioperative systemic therapy versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: a Phase 2 randomized clinical trial","volume":"156","author":"Rovers","year":"2021","journal-title":"JAMA Surg"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","article-title":"Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O","volume":"37","author":"Cavaliere","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejso.2016.09.015","article-title":"Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis","volume":"43","author":"Leung","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3393\/ac.2021.00290.0041","article-title":"Molecular characterization of dysplasia-initiated colorectal cancer with assessing matched tumor and dysplasia samples","volume":"38","author":"Jung","year":"2021","journal-title":"Ann Coloproctol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:11:25Z","timestamp":1756062685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000000809","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"2023-07-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}